Back to search

Article

Strain-level Screening of Human Gut Microbes Identifies Blautia Producta as a Novel Anti-hyperlipidemic Probiotic Via the Production of 12-methylmyristic Acid

2021-10-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Compelling evidence has linked the commensal gut microbiota to human metabolic syndromes and provided new therapeutic potentials against diseases, such as hyperlipidemia. However, the precise regulatory effect of each bacterial species on human lipid homeostasis remains largely unknown.<bold>Results:</bold> We set up a cell-based high-throughput screening platfo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb407ee3-02f9-5edf-9e10-8531d1573ef9
DOI
10.21203/rs.3.rs-989302/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Strain-level Screening of Human Gut Microbes Identifies Blautia Producta as a Novel Anti-hyperlipidemic Probiotic Via the Production of 12-methylmyristic AcidDOI 10.21203/rs.3.rs-989302/v1
The Probiotic Potential of Enterococcus faecium 140623, the Production Strain for Lactasin Tablets: Safety Assessment and Modulating Host MetabolismSemantic proximity
Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle HabitsSemantic proximity
Probiotic-derived strain-specific metabolites ameliorate metabolic dysfunction-associated steatotic liver disease through modulation of the gut-liver axisSemantic proximity
Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseasesSemantic proximity
Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studiesSemantic proximity
Modulation of the Gut Microbiome by Novel Synthetic Glycans for the Production of Propionate and the Reduction of Cardiometabolic Risk FactorsSemantic proximity
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver diseaseSemantic proximity
The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity
The human-derived novel gut commensal Luoshenia tenuis regulates body weight and food intake in miceSemantic proximity
Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome– a pilot studySemantic proximity
Christensenella minuta DSM 22607 and food restriction manage age-related disorders in vivoSemantic proximity
A novel plant-based food to make the benefits of the Mediterranean diet accessible to not adhering peopleSemantic proximity
Select a neighboring publication to make it the new centre.